PharmaVOICE - 
September 2003
Purchase Issue

In Every Issue
Talent Pool
90 S e p t e mb e r 2003 [...]
By
E-Media
86 S e p t e mb e r 2003 [...]
By
What’s New
weaknesses of a product’s message,” says Howard Ziment, CEO.“What the [...]
By
On the Calendar
September 1819,2003,Westin Princeton — Princeton,N.J. 2nd Annual Edetailing The Center [...]
By
PharmaTrax
76 S e p t e m b e r [...]
By
For Art’s Sake
CREATIVE review There is a fundamental honesty and integrity in [...]
By
PharmaOutlet
Direct to consumer advertising has received a great deal of [...]
By

Charles Hunt

PharmaCase
70 S e p t e mb e r 2003 [...]
By
Opinions
8 S e p t e mb e r 2003 [...]
By
Raise Your Voice — Letters
6 S e p t e m b e r [...]
By
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh [...]
By

Taren Grom, Editor

On The Cover

A Special Breed of Leader
12 S e p t e mb e r 2003 PharmaVOICE BREEDOFLEADER I got into this business with the ultimate objective to help people. I can’t think of a better way to begin every day. The minute I get in the car and start driving to work I get excited because I know what I [...]
By

Elisabeth Pena and Taren Grom

Features

Joseph F. Donahue-Destined for Science
Destined for Science As one of the new breed of 40something business leaders, Joseph F. Donahue is bringing a multidiscipline skill set to help LION bioscience become the leader in improving research productivity within the lifesciences industry. BY KIM RIBBINK 64 S e p t e mb e r 2003 PharmaVOICE JOSEPH Donahue esearching and [...]
By

Kim Ribbink

The Great Divide
58 S e p t e mb e r 2003 PharmaVOICE ALL TOO OFTEN MARKETING AND R&D ARE AT ODDS ON HOW TO BEST ALLOCATE RESOURCES TO SUPPORT THE PIPELINE.THIS DISCONNECT BETWEEN SALES AND SCIENCE THREATENS THE FUTURE OF THE PHARMACEUTICAL INDUSTRY. The GREATDivide IN AN EXCLUSIVETO PHARMAVOICE, MICHAEL MENARD,PRESIDENT OF THE GENSIGHT GROUP INC., [...]
By
A Temporary Solution
50 S e p t e mb e r 2003 PharmaVOICE clinical trial staffing A T E M P O R A R Y S O L U T I O N the days of temps as lowwage, lowstatus secretaries without benefits have passed. Now highly specialized — and often highly paid — scientists and [...]
By
The Trials of Youth: Bringing Children Into Clinical Research
42 S e p t e mb e r 2003 PharmaVOICE Trialsof Youth The After the fall of the pediatric rule, Congress is moving forward to provide the Food and Drug Administration with the authority to mandate the testing of prescription drugs in children. B R I N G I N G C H I [...]
By

Denise Myshko

Prevention Through Intervention
It’s in the pharmaceutical industry’s best interest to develop disease-management programs, which can bring additional sales and long-term relationships with payer organizations.
By

Elisabeth Pena

FEEDBACK